IFPMA Note for Guidance on sponsorship of events and meetings (2023 update)
Advancing medical knowledge and improving global public health remains a priority for IFPMA representing the research-based pharmaceutical industry.
Collaborations between healthcare professionals (HCPs) and the pharmaceutical industry are essential and ensure that patients have access to the medicines they need and that healthcare professionals have up-to-date comprehensive information about the diseases they treat and the medicines they prescribe.
IFPMA members remain committed to activities that provide scientific and educational content to healthcare professionals and advance their medical knowledge and expertise.
The purpose of this document is to provide more information in relation to relevant requirements of the IFPMA Code of Practice.